FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

Probe Leqembi, Kisunla Trials: Public Citizen

[ Price : $8.95]

The Public Citizen Health Research Group calls for a federal investigation into clinical trials for two Alzheimers drugs that may ...

Baxter Class 1 Recall of Life2000 Ventilator

[ Price : $8.95]

Baxter Healthcare recalls (Class 1) its Life2000 ventilator to update the use instructions after finding that the device may fail ...

Pfizers Changes to Total Lifecycle Patient Preference Guide

[ Price : $8.95]

Pfizer submits pages of recommended changes to an FDA draft guidance on incorporating voluntary patient preference information ove...

Researchers Find Alzheimers Potential in Semaglutide

[ Price : $8.95]

Researchers from Case Western Reserve University School of Medicine report that semaglutide may reduce the risk of Alzheimer's dis...

ASHP Sees 277 Active Drug Shortages

[ Price : $8.95]

The American Society of Health-System Pharmacists says there were 277 drug shortages as of September, down from an all-time high o...

Safety Alert on Regener-Eyes Eye Drops

[ Price : $8.95]

An FDA safety alert warns about Regener-Eyes manufactured by Regenerative Processing Plant because the eye drops likely contain am...

Priority Review for Glioma Imaging Agent

[ Price : $8.95]

FDA accepts for priority review a Telix NDA for Pixclara (18F-floretyrosine), a positron emission tomography agent for glioma imag...

FDA to Study Adherence and Patient Preference in Ads

[ Price : $8.95]

FDA says the CDER Office of Prescription Drug Promotion will research how consumers and primary care physicians respond to drug ad...

AI Forcing FDA to Rethink Everything: Califf

[ Price : $8.95]

FDA commissioner Robert Califf says the agency is being forced by artificial intelligence to rethink how it conducts business.

Alto Neuro Depression Study Fails

[ Price : $8.95]

Alto Neuroscience says a study of its major depressive disorder investigational drug did not meet its primary endpoint.